The inhibition of PTK7 has been suggested as a novel therapeutic target for various cancers such as colorectal cancer and atypical teratoid rhabdoid tumors31,32, and some anticancer agents under development involve PTK7-targeted antibody-drug conjugates33 or PTK7 aptamers34. The gene discussed is PTK7; the disease is colorectal cancer.